Carbohydrate based meningococcal vaccines: past and present overview

Area of Science:

• Microbiology
• Immunology
• Vaccinology

Background:

• Neisseria meningitidis is a leading global cause of bacterial meningitis, particularly affecting young children and adolescents.
• Invasive strains possess polysaccharide capsules differentiating 12 serogroups; serogroups A, B, C, W, X, and Y are responsible for most human infections.
• Carbohydrate-based vaccines, including mono- and multi-valent formulations, are available or in development for meningococcal disease prevention.

Purpose of the Study:

• To provide a comprehensive overview of past and present strategies for the production of meningococcal glycoconjugate vaccines.
• To highlight the evolution of vaccine development against Neisseria meningitidis.

Main Methods:

• Review of scientific literature on meningococcal vaccine development.
• Analysis of historical and contemporary approaches to glycoconjugate vaccine production.

Main Results:

• Established methods for producing meningococcal glycoconjugate vaccines have been refined over time.
• Current research focuses on developing novel and improved vaccine formulations.

Conclusions:

• Glycoconjugate vaccines are essential tools in controlling Neisseria meningitidis infections.
• Continued innovation in production methodologies is key to advancing meningococcal disease prevention globally.